ASTS
AST SpaceMobile, Inc.
ASTS has the edge over WRAP overall, supported by stronger modeled upside.
WRAP
Wrap Technologies, Inc.
WRAP has slightly lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WRAP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
WRAP's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
WRAP PE Valuation
WRAP has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
WRAP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect WRAP's losses to grow, with revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
WRAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.28 | -$0.07 |
| Q1 2026 | -$0.31 | -$0.15 |
| Q4 2025 | -$0.22 | -$0.06 |
| Q3 2025 | -$0.31 | +$0.11 |
| Q2 2025 | -$0.21 | +$0.32 |
| Q1 2025 | -$0.16 | +$0.47 |
| Q4 2024 | -$0.16 | +$0.57 |
| Q3 2024 | -$0.42 | -$0.04 |
WRAP has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over WRAP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
WRAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.1M | +103% |
| Q1 2026 | $1.1M | +45% |
| Q4 2025 | $1.4M | +62% |
| Q3 2025 | $1.5M | +151% |
| Q2 2025 | $1M | -36% |
| Q1 2025 | $765K | -48% |
| Q4 2024 | $865K | +47% |
| Q3 2024 | $593K | -84% |
WRAP's revenue is recovering but still below its 2023 peak: $2M last quarter, up 103% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -110% | +173 points |
| Q1 2026 | -429% | +83 points |
| Q4 2025 | -281% | +255 points |
| Q3 2025 | -185% | +426 points |
| Q2 2025 | -282% | -81 points |
| Q1 2025 | -513% | -232 points |
| Q4 2024 | -536% | +590 points |
| Q3 2024 | -611% | -536 points |
WRAP has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
WRAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.4M | -$493K |
| Q1 2026 | -$1.3M | +$1.8M |
| Q4 2025 | -$2.7M | -$1.5M |
| Q3 2025 | -$2.7M | -918% |
| Q2 2025 | -$1.9M | +$1.6M |
| Q1 2025 | -$3.1M | +$667K |
| Q4 2024 | -$1.2M | +$2.7M |
| Q3 2024 | $330K | +$12.5M |
WRAP has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over WRAP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
WRAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +1.7M shares |
| 1 year | +10% | +5.1M shares |
| 3 years | +34% | +14M shares |
| 5 years | +46% | +17.6M shares |
| Available history | +88% | +26.1M shares |
WRAP has 56M diluted shares, up 10% from a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WRAP Net Leverage
WRAP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
WRAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.9 | Neutral |
| Stochastic | 18.3 | Oversold |
WRAP's weekly RSI is 41 (neutral) and its Stochastic is 18 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
WRAP PE vs Technology Sector
WRAP has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over WRAP on trend strength, trading above more of its moving averages.
WRAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 5.3% below |
| 20 week MA | $1.58 | 22% below |
| 50 week MA | $1.71 | 27% below |
| 100 week MA | $1.79 | 31% below |
| 200 week MA | $1.89 | 34% below |
WRAP is in a downtrend: it's below all five of its weekly moving averages, and 34% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
WRAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.40 | $5.70 | -11% |
| 2021 | $5.70 | $4.40 | -23% |
| 2022 | $4.40 | $1.78 | -60% |
| 2023 | $1.78 | $3.10 | +74% |
| 2024 | $3.10 | $1.81 | -42% |
| 2025 | $1.81 | $2.17 | +20% |
| 2026 YTD | $2.17 | $1.24 | -43% |
WRAP has the edge over ASTS on returns for 2026, with the stronger performance.